FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and concerns a method for stabilizing a human blood plasma protein with a molecular weight greater than 10 kDa by adding melycytosis to a solution containing a human blood plasma protein with a molecular weight greater than 10 kDa, which is pharmaceutically or a biologically significant human blood plasma protein or recombinant human plasma protein selected from a group consisting of fibrinogen, factor FVIIa, von Willebrand factor, antithrombin, C1 inhibitor, polyclonal antibodies (IgG), monoclonal antibodies, factor H, factor I, hepatocyte growth factor, plasminogen, α-1-microglobulin, vWF and α1-antitrypsin. Group of inventions also relates to the use of melicycosis for stabilizing said human plasma proteins.
EFFECT: group of inventions provides stabilizing a solution containing said human blood plasma proteins.
24 cl, 11 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL STABILISER FOR PHARMACEUTICAL PROTEINS | 2011 |
|
RU2571496C2 |
| STABLE, ALBUMIN-FREE, LYOPHILIZED COMPOSITION OF RECOMBINANT FACTOR VIII | 1997 |
|
RU2201252C2 |
| STABILISED IX FACTOR AND TREGALOSE- CONTAINING COMPOSITIONS | 2008 |
|
RU2481823C2 |
| METHOD OF PRODUCING FACTOR VIII, HAVING IMPROVED RATIO FVIII:C/FVIII:AG | 2015 |
|
RU2695428C2 |
| NEW ALBUMIN-FREE COMPOSITIONS OF FACTOR VIII | 2000 |
|
RU2244556C2 |
| NEW PROTECTIVE COMPOSITIONS FOR RECOMBINANT FACTOR VIII | 2009 |
|
RU2510279C2 |
| PURIFICATION OF FACTOR VIII SUBTYPES | 2018 |
|
RU2800431C2 |
| METHOD OF PRODUCING LYOPHILIZED PELLETS CONTAINING A VIII FACTOR | 2016 |
|
RU2735082C2 |
| METHOD OF PRODUCING POWDER CONTAINING PROTEIN WHICH IS HUMAN BLOOD COAGULATION FACTOR AND LACTIC ACID-BASED POLYMER | 2016 |
|
RU2702740C2 |
| HYDROXYALKYL STARCH AND G-CSF CONJUGATES | 2004 |
|
RU2370281C2 |
